Skip to main content
. 2019 Jul 2;2019(7):CD012582. doi: 10.1002/14651858.CD012582.pub2

Halkett 2015.

Trial name or title Care‐IS trial
Methods Multicentre prospective phase III randomised controlled trial
Participants Adult primary carers of a patient with high‐grade glioma who 1. is currently undergoing active treatment and is within 2 months of diagnosis; and 2. is currently attending the outpatient departments of 1 of the participating sites.
The caregiver should furthermore 1. aged >18 years; 2. understand and speak English; 3. have no mental, cognitive, or functional disability; 4. be willing and able to comply with study requirements; 5. have no familial, sociological, or geographical condition that might hamper compliance; 6. have no severe intercurrent medical or psychotic disease that would hinder the ability to participation in the study.
Interventions The Care‐IS intervention is guided by a nurse and will consist of: 1. a telephone needs assessment; 2. access to a tailored resource file for the caregiver based on the needs that had been identified; 3. an educational and supportive home visit from the nurse; 4. monthly telephone check‐ups.
Outcomes Primary outcomes
  • Caregiver preparedness (Preparedness for Caregiving Scale)

  • Caregiver distress (Distress Thermometer)


Secondary outcomes
  • Anxiety and depression (Hospital Anxiety and Depression Scale)

  • QoL (Caregiver QoL Index – Cancer)

  • Caregiver competence (Carer Competence Scale)

  • Supportive care needs (Partner and Caregivers Supportive Care Needs Scale/Brain Tumour Specific Supportive Carer Needs for Carers Survey)

  • Health economic cost‐consequences (checklist of services used)

Starting date 2015
Contact information G.Halkett@curtin.edu.au
Notes